Dr Charles Tannock MEP views the future of biomedical research
14th December 2012
Dr Charles Tannock MEP met Cancer Research UK scientists in London last week to learn about the charity’s world class research and the future vision for biomedical advances in the UK.
The MEP for London witnessed firsthand the groundbreaking scientific research carried out by scientists and doctors at the London Research Institute. They then visited the site of the new Francis Crick Institute (The Crick) which will be the largest bio-medical research laboratory in Europe when it opens in 2015.
Dr Tannock said: “This was a great opportunity to see the fantastic work Cancer Research UK is doing and the contribution that the new Crick Institute will make to the future of biomedical research in the UK. It highlighted why it’s so important we continue to support groundbreaking research that will help ensure cancer patients have access to the best possible treatment.”
Cancer Research UK’s current research centre in London, the LRI, has an international reputation for basic cancer biology research, and is due to move to the Crick’s laboratories in 2015. The Crick will be a world-class centre for interdisciplinary medical sciences, research and innovation. It will serve to stimulate scientists and medical professionals to work together in inspiring new ways.
The Crick is a partnership between: Cancer Research UK, the Medical Research Council, the Wellcome Trust, UCL (University College London), Imperial College London and King's College London.
Cancer Research UK is the only partner raising funds philanthropically to help build the Institute through its ‘Create the Change’ campaign. This aims to raise £100 million and signals Cancer Research UK's commitment to the development of The Crick and the future of cancer research.
The Crick, located near St. Pancras, sits amid a cluster of academic, scientific and medical organisations. Its location will allow it to attract the very best researchers across a variety of fields, and establish the Institute as a beacon for global scientific and medical communities. It will be well placed to harness the power of the NHS, to accelerate the transition of research discovery into clinical benefits.
Staff will be given access to the latest technologies, multi-disciplinary talent and the world-class clinical facilities nearby where their ideas can flourish. Researchers will be led by Sir Paul Nurse, Nobel Prize winner, President of the Royal Society, former President of Rockefeller University and former CEO of Cancer Research UK.
Sara Osborne, Head of Policy at Cancer Research UK, said: “We were delighted that Dr Tannock had the opportunity to witness first-hand the exciting development of the Francis Crick Institute and learn how the pioneering life-saving research the Crick will undertake will prove to be a real game changer in our fight against cancer.”
Cancer survival rates in the UK have doubled in the last forty years and Cancer Research UK’s work has been at the heart of that progress. Thanks to the generosity of its supporters, the charity was able to spend more than £332 million of research in 2011/12, supporting the work of more than 4,000 researchers, doctors and nurses.